Hematology
Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
Karyopharm Therapeutics Inc.
PR-11-24-NI-107Nov 18, 2024
Oncology
IMBRUVICA® (ibrutinib) Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR
AbbVie
PR-M12-18-NI-017Dec 06, 2018
Oncology
New Phase 3 CASSINI Data Presented on the Use of XARELTO® (rivaroxaban) for Venous Thromboembolism (VTE) Prevention in High-Risk Cancer Patients
Janssen Pharmaceutical Companies
PR-M12-18-NI-020Dec 06, 2018
Clinical Trials
Late-Breaking Clinical Trials Advance Targeted Therapies for Patients with CLL and Multiple Myeloma
The American Society of Hematology (ASH)
PR-M12-18-NI-018Dec 06, 2018
Stem Cells
Platelets Grown from Stem Cells May be Alternative to Donated Platelets
Blood/American Society of Hematology
PR-M12-18-NI-006Dec 04, 2018